Sign inJoin waitlistJoin the waitlist

Meng Chen

Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine · Stanford Health Care

Credentials: · · · · ·

History

Stanford Health Care
Present
Stanford Health Care
Present

University of California (San Diego) Medical Center
2017–2018
Internal Medicine
Ronald Reagan UCLA Medical Center
2015–2016
Allergy and Immunology
University of California (San Diego) Medical Center
2013–2015
University of California, San Francisco School of Medicine
2009–2013

Research

Light signal transduction in higher plants
Review · Annual Review of Genetics · 2004 · First of 3 authors · Corresponding · 653 citations
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci
Nature Genetics · 2010 · 370 citations
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant
Nature Communications · 2016 · 256 citations

Colin Dinney
13 papers
Kari Nadeau
6 papers
Ashish Kamat
5 papers
Anna Arroyo
4 papers
David Chang
4 papers
HG
Herbert Grossman
4 papers
MS
Margaret Spitz
4 papers
SC
Stephen Chanock
4 papers
CF
Charles Feng
3 papers
Cristina Ivan
3 papers
Dana Giza
3 papers · 3 as a resident
DA
Desiree Azizoddin
3 papers

Grants

Cellular Programming by Plant Photoreceptor Signaling
National Institute of General Medical Sciences · R35
Contact PI · $527K · University of California Riverside
2026–2031
Genetic and Biochemical Dissection of Anterograde Signaling for Controlling Plastid Transcription
National Institute of General Medical Sciences · R01
Contact PI · $2.3M · University of California Riverside
2020–2028
Function of Photobodies in Arabidopsis Photoreceptor Signaling
National Institute of General Medical Sciences · R01
Contact PI · $5.8M · University of California Riverside
2010–2025
Administrative Supplement to Purchase a Plate Reader
National Institute of General Medical Sciences · R01
Contact PI · $370.5K · University of California Riverside
2000–2024

Clinical trials

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2025–2027